Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07058818 · ClinicalTrials.gov registry record · NA
Tailored Resistance Training After Adverse Pregnancy Outcomes
A NA study of Postpartum and Adverse Pregnancy Outcomes, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07058818: Recruiting NA study of Postpartum and Adverse Pregnancy Outcomes, sponsored by University of Michigan.
NCT07058818 is a NA study of Postpartum and Adverse Pregnancy Outcomes that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 10 participants, below the 250-participant average among 16 other Postpartum trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07058818, a NA study of Postpartum and Adverse Pregnancy Outcomes, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 7-10 postpartum people with recent adverse pregnancy outcomes (APOs: preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth) will be invited to complete 4 weeks of a resistance training intervention, including associated incentives, communication, and marketing materials.
Primary Outcome
Proportion of prescribed resistance exercise sessions completed
Conditions Studied
Interventions
- BEHAVIORAL Resistance training
Study Locations (1)
Michigan
- School of Kinesiology - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01-08 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07058818 shows while recruiting
NCT07058818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 250-participant average among 16 other Postpartum trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Resistance training is the first listed.
NCT07058818 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07058818 about?
NCT07058818 is a clinical study titled "Tailored Resistance Training After Adverse Pregnancy Outcomes". Approximately 7-10 postpartum people with recent adverse pregnancy outcomes (APOs: preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth) will be invited to complete 4 weeks of a resistance training intervention, ...
What is the current status of trial NCT07058818?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01-08. Estimated completion is 2026-05.
What conditions does trial NCT07058818 study?
This clinical trial studies the following conditions: Postpartum, Adverse Pregnancy Outcomes.
What interventions are being tested in trial NCT07058818?
The interventions under investigation include: Resistance training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07058818?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07058818 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07058818's enrollment target sits among peer trials
10 16th of 16 the lowest of 16 other Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
RECRUITING · NA
-
Orthopaedic Manual Physical Therapy as Part of the Postpartum Care Continuum
RECRUITING · NA
-
Substance Use in Pregnant People - Optimizing Retention in Treatment
RECRUITING · NA
-
Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI